0000950170-24-042335.txt : 20240405
0000950170-24-042335.hdr.sgml : 20240405
20240405165823
ACCESSION NUMBER: 0000950170-24-042335
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240403
FILED AS OF DATE: 20240405
DATE AS OF CHANGE: 20240405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Khayal Tamer I
CENTRAL INDEX KEY: 0001430462
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38891
FILM NUMBER: 24827241
MAIL ADDRESS:
STREET 1: TRANSMEDICS INC
STREET 2: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TransMedics Group, Inc.
CENTRAL INDEX KEY: 0001756262
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
BUSINESS PHONE: 9785520900
MAIL ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
4
1
ownership.xml
4
X0508
4
2024-04-03
0001756262
TransMedics Group, Inc.
TMDX
0001430462
Khayal Tamer I
C/O TRANSMEDICS GROUP, INC.
200 MINUTEMAN ROAD
ANDOVER
MA
01810
false
true
false
false
Chief Commercial Officer
true
Common Stock
2024-04-03
4
M
false
5053
13.28
A
30238
D
Common Stock
2024-04-03
4
S
false
5053
80.06
D
25185
D
Common Stock
2024-04-04
4
M
false
2030
13.28
A
27215
D
Common Stock
2024-04-04
4
M
false
2917
16.14
A
30132
D
Common Stock
2024-04-04
4
S
false
4947
80.36
D
25185
D
Common Stock
14776
I
By the Khayal Family 2021 Irrevocable Trust
Common Stock
11051
I
By the Tamer Ibrahim Ahmed Khayal Trust
Stock Option (Right to Buy)
13.28
2024-04-03
4
M
false
5053
0.00
D
2032-02-22
Common Stock
5053
26947
D
Stock Option (Right to Buy)
13.28
2024-04-04
4
M
false
2030
0.00
D
2032-02-22
Common Stock
2030
24917
D
Stock Option (Right to Buy)
16.14
2024-04-04
4
M
false
2917
0.00
D
2030-02-27
Common Stock
2917
12729
D
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.00 to $80.205, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.00 to $80.675, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.
The option is fully vested.
By: /s/ Stephen Gordon, Attorney-in-Fact
2024-04-05